Key result
The presence of a chronic total occlusion in patients with acute myocardial infarction and cardiogenic shock was associated with higher in-hospital mortality (OR 1.20; 95% CI 1.16-1.23; p<0.001).
Why the study?
Data are limited regarding the prevalence and outcomes of coronary chronic total occlusions in patients with acute myocardial infarction and cardiogenic shock.
Does the presence of a chronic total occlusion (CTO) increase in-hospital mortality in patients with acute myocardial infarction and cardiogenic shock?
Cohort (n=163,628)
Yes
Does the presence of a chronic total occlusion (CTO) increase in-hospital mortality in patients with acute myocardial infarction and cardiogenic shock?
Odds Ratio: 1.2 (95% CI 1.16–1.23)
p-value: p=< 0.001
In patients with acute myocardial infarction complicated by cardiogenic shock, the presence of a concurrent chronic total occlusion is associated with a 20% increased odds of in-hospital mortality.
CTO in AMI-cardiogenic shock signals higher mortality; leaves open whether revascularization improves outcomes.
Background There are limited data on the prevalence and outcomes of chronic total occlusions (CTO) of the coronary artery in acute myocardial infarction with cardiogenic shock (AMI-CS) patients. Methods Using the National Inpatient Sample, all admissions with AMI-CS that underwent diagnostic angiography between January 1, 2008, and December 31, 2014, were included. CTO, percutaneous coronary intervention (PCI), comorbidities and concomitant cardiac arrest was identified for all admissions. Outcomes of interest included temporal trends, in-hospital mortality, and resource utilization in cohorts with and without CTO. Results In this 7-year period, 163,628 admissions with AMI-CS admissions met the inclusion criteria, with 68% being ST-elevation AMI-CS. CTO was noted in 27,343 (16.7%) admissions, with an increase in prevalence during the study period. The cohort with CTOs was more likely to be male and bearing private insurance. The CTO cohort had higher cardiovascular comorbidity, higher rates of cardiac arrest and higher use of PCI and mechanical circulatory support. The presence of a CTO was independently associated with higher in-hospital mortality (adjusted odds ratio 1.20 [95% confidence interval 1.16–1.23]; p < 0.001). The cohort with CTO had lower resource utilization (hospital stay and hospitalization costs) but was discharged more frequently to other hospitals. The presence of a CTO was associated with higher in-hospital mortality in the sub-groups of ST-elevation AMI-CS (31.5% vs. 28.7%; p < 0.001) and non-ST-elevation AMI-CS (24.8% vs. 23.2%; p < 0.001). Conclusions In this cohort of AMI-CS admissions that underwent diagnostic angiography, the presence of a CTO identified a higher risk cohort that had higher in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
Vallabhajosyula et al. (2019) conducted a cohort in Acute myocardial infarction with cardiogenic shock (n=163,628). Chronic total occlusion (CTO) vs. No chronic total occlusion was evaluated on In-hospital mortality (OR 1.20, 95% CI 1.16-1.23, p=< 0.001). The presence of a chronic total occlusion in patients with acute myocardial infarction and cardiogenic shock was associated with higher in-hospital mortality (OR 1.20; 95% CI 1.16-1.23; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: